Receptor for hyaluronan acid–mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia-Reference-Cited by-同舟云学术

Receptor for hyaluronan acid–mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

Published:2002-09 Issue:9 Volume:30 Page:1029-1035
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Greiner Jochen,Ringhoffer Mark,Taniguchi Masanori,Schmitt Anita,Kirchner Dieter,Krähn Gertraud,Heilmann Volker,Gschwend Jürgen,Bergmann Lothar,Döhner Hartmut,Schmitt Michael

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference49 articles.

1. High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults;Phillips;Blood,1991

2. Varying intensity of postremission therapy in acute myeloid leukemia;Cassileth;Blood,1992

3. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia;Zittoun;N Engl J Med,1995

4. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients;Kolb;Blood,1990

5. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients;Kolb;Blood,1995

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis;Cancers;2024-05-16

2. Receptor for hyaluronan‐mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients;The Journal of Pathology;2023-04-26

3. The importance of RHAMM in the normal brain and gliomas: physiological and pathological roles;British Journal of Cancer;2022-10-07

4. The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities;Frontiers in Oncology;2022-08-10

5. Enhanced stimulation of antigen‐specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti‐programmed death 1 antibody;British Journal of Haematology;2022-07-07